GREY:AKLPF - Post by User
Post by
zutfieon Aug 21, 2010 8:18am
634 Views
Post# 17371343
insiders
insiders Akela Pharma Inc. (AKL) | As of August 20th, 2010 |
| Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | # or value acquired or disposed of | Unit Price |
| Aug 20/10 | Aug 20/10 | Rieder, Robert | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 7,000 |
.080 |
| Aug 20/10 | Aug 20/10 | Rieder, Robert | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 43,000 |
.075 |
| Aug 20/10 | Aug 16/10 | Rieder, Robert | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 50,000 |
.084 |
| Apr 09/10 | Apr 06/10 | Ingalls & Snyder, LLC | Direct Ownership | Common Shares | 90 - Change in the nature of ownership | -11,000 | |
| Jul 14/09 | Oct 10/07 | Williams III, Robert O. | Direct Ownership | Common Shares | 37 - Stock split or consolidation | -2,083,899 | |
| Jul 14/09 | Jan 25/07 | Williams III, Robert O. | Direct Ownership | Common Shares |  00 - Opening Balance-Initial SEDI Report | | |
| Jul 03/09 | May 21/09 | Rieder, Robert | Direct Ownership | Options | 36 - Conversion or exchange | 8,875 | $3.240 |
| Jul 03/09 | May 21/09 | Rieder, Robert | Direct Ownership | Options | 36 - Conversion or exchange | 7,100 | $2.390 |
| Jun 24/09 | May 21/09 | McKee, Gregory | Direct Ownership | Options | 36 - Conversion or exchange | 6,212 | $73.240 |